 |
 |
 |
 |
 |
 |
Treatment Name: |
 |
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) |
 |
 |
 |
 |
Phase: |
 |
Phase 3 |
 |
 |
 |
 |
 |
 |
Treatment ID#: |
 |
1924 |
 |
 |
 |
 |
Age Group: |
 |
Adults Only |
 |
 |
 |
 |
 |
 |
Min Karnofsky Score: |
 |
70: Cares for self, unable to perform normal activity or to do active work |
 |
 |
 |
 |
Conditions: |
 |
Prior Surgery is Allowed Prior Radiation is Sometimes Allowed Prior Chemotherapy is Sometimes Allowed |
 |
 |
 |
 |
 |
 |
Last Updated: |
 |
09/30/2009 |
 |
 |
 |
 |
Tumor Types: |
 |
Glioblastoma Multiforme |
 |
 |
 |
 |
 |
 |
 |
Comments: |
 |
See http://virtualtrials.com/news3.cfm?item=4336
for results of a small pilot study of this treatment. |
 |
 |
 |
 |
 |
 |
Treatment Type: |
 |
Chemotherapy Less-Toxics |
 |
 |
 |
 |
Contact: |
 |
Nicholas G. Avgeropoulos M.D. Medical Director, Neuro-Oncology Florida Hospital FHCI, 2501 North Orange Avenue Neuro-Oncology Center, Suite 581 Orlando, FL 32804 USA Phone: 407.303.2770 Fax: 407.303.3268 E-mail: dr-nick@neuro-oncology.net Website: neuro-onc.net |
 |
 |
- Last updated refers to the date when our listing for each treatment was last updated.
- ID is a combination of our internal ID and the official ID for the trial, if any.
- Min Karnofsky is a general guide to how well you have to function to use this treatment
|
|